Overview

Update
Total Equity Funding
Undisclosed Amount in 1 Round from 1 Investor
Most Recent Funding
Venture on July 11, 2012 / Undisclosed Amount
Headquarters:
Düsseldorf
Description:
Epivios GmbH, a Düsseldorf, Germany-based developer of molecular diagnostic cancer tests. Led by Nicole Groth and Dr Simeon Santourlidis,
Categories:
Biotechnology
Website:
http://epivios.de/en

Company Details

Update

Epivios GmbH, a Düsseldorf, Germany-based developer of molecular diagnostic cancer tests. Led by Nicole Groth and Dr Simeon Santourlidis, Epivios was founded in 2011 as a spin-off of the Heinrich Heine University of Düsseldorf. Its interdisciplinary team, comprising doctors and biologists, has been working since 2009 on innovative epigenetic procedures for cancer diagnosis. The company’s epigenetic platform technology includes a new kind of standardization tool that allows the comparison of samples with differing genetic constitution for the first time. Epivios´s new procedure also analyzes sequences, which spread across the entire genome.

Funding Rounds (1) - undisclosed

Update
DateAmount / RoundValuationLead InvestorInvestors
Jul, 2012undisclosed amount / Venture1

Investors (1)

InvestorRound(s)Partner(s)
Venture-

News (1)

Update
DateNews
Jul 11, 2012FinSMEs - FinSMEs

Offices/Locations (1)

Update
  • Office

    Düsseldorf Moorenstr. 5,

    Geb. 14.80

    Düsseldorf, 40225

    DEU

Add Acquisitions

Add Current Team

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos